Prevalencia de polifarmacia y factores asociados en adultos mayores en España: datos de la Encuesta Nacional de Salud 2017
- 22 February 2019
- journal article
- research article
- Published by Elsevier BV in Medicina Clinica
- Vol. 153 (4), 141-150
- https://doi.org/10.1016/j.medcli.2018.12.013
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Medicalización de la vida. «Etiquetas de enfermedad: todo un negocio.»Atencion Primaria, 2013
- Clinical consequences of polypharmacy in elderlyExpert Opinion on Drug Safety, 2013
- Exclusion of Older Adults from Ongoing Clinical Trials About Type 2 Diabetes MellitusJournal of the American Geriatrics Society, 2013
- Polypharmacy in Nursing Home in Europe: Results From the SHELTER StudyThe Journals of Gerontology: Series A, 2012
- Geriatric Drug EvaluationArchives of Internal Medicine, 2011
- Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteriaBritish Journal of Clinical Pharmacology, 2011
- Control de la presión arterial en una población hipertensa española ≥ 65 años asistida en Atención Primaria. Datos del estudio PRESCAP 2006Medicina de Familia. SEMERGEN, 2009
- Frail elderly patients in primary care—their medication knowledge and beliefs about prescribed medicinesEuropean Journal of Clinical Pharmacology, 2008
- Inappropriate prescribing in the elderlyJournal of Clinical Pharmacy & Therapeutics, 2007
- Studies of Illness in the AgedJAMA, 1963